Alaunos Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRT and other ETFs, options, and stocks.About TCRT
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy.
TCRT Key Statistics
Stock Snapshot
As of today, Alaunos Therapeutics(TCRT) shares are valued at $2.07. The company's market cap stands at 5.06M, with a P/E ratio of -0.95.
On 2026-07-09, Alaunos Therapeutics(TCRT) stock moved within a range of $1.99 to $2.08. With shares now at $2.07, the stock is trading +4.0% above its intraday low and -0.5% below the session's peak.
Trading volume for Alaunos Therapeutics(TCRT) stock has reached 18.74K, versus its average volume of 23.74K.
The stock's 52-week range extends from a low of $1.67 to a high of $6.20.
The stock's 52-week range extends from a low of $1.67 to a high of $6.20.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.